These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26890687)

  • 1. How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatum.
    Navntoft CA; Dreyer JK
    Mov Disord; 2016 Mar; 31(3):280-9. PubMed ID: 26890687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three mechanisms by which striatal denervation causes breakdown of dopamine signaling.
    Dreyer JK
    J Neurosci; 2014 Sep; 34(37):12444-56. PubMed ID: 25209283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.
    Zeng X; Shen H; Zhao J; Cai Q; Wang C; Xu Q
    Brain Res; 2012 Apr; 1450():166-73. PubMed ID: 22424788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EFFECT OF QUERCETIN ON NEURODEGENERATIVE AND COMPENSATORY PROCESSES IN NIGROSTRIATAL SYSTEM IN A MODEL OF PRECLINICAL PARKINSON''S DISEASE STAGE IN RATS].
    Ekimova IV; Plaksina DV
    Ross Fiziol Zh Im I M Sechenova; 2016 Jun; 102(6):647-58. PubMed ID: 30192489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.
    Horst CH; Schlemmer F; de Aguiar Montenegro N; Domingues ACM; Ferreira GG; da Silva Ribeiro CY; de Andrade RR; Del Bel Guimarães E; Titze-de-Almeida SS; Titze-de-Almeida R
    Neurochem Res; 2018 Nov; 43(11):2132-2140. PubMed ID: 30267378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.
    Kuter K; Kratochwil M; Marx SH; Hartwig S; Lehr S; Sugawa MD; Dencher NA
    Arch Physiol Biochem; 2016 Dec; 122(5):238-256. PubMed ID: 27467289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant plasticity and "learned" motor inhibition in Parkinson's disease.
    Zhuang XX
    Sheng Li Xue Bao; 2012 Oct; 64(5):543-9. PubMed ID: 23090495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
    De Luca MA; Cauli O; Morelli M; Simola N
    J Neurochem; 2014 Nov; 131(3):284-9. PubMed ID: 24989117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice.
    Sgobio C; Sun L; Ding J; Herms J; Lovinger DM; Cai H
    Sci Rep; 2019 Mar; 9(1):4857. PubMed ID: 30890737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
    Piggott MA; Perry EK; Marshall EF; McKeith IG; Johnson M; Melrose HL; Court JA; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry RH
    Biol Psychiatry; 1998 Oct; 44(8):765-74. PubMed ID: 9798081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.
    Lemos JC; Friend DM; Kaplan AR; Shin JH; Rubinstein M; Kravitz AV; Alvarez VA
    Neuron; 2016 May; 90(4):824-38. PubMed ID: 27196975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restorative strategies for the dopaminergic nigrostriatal projection pathway.
    Nikkhah G
    Acta Neurochir Suppl; 2013; 117():79-85. PubMed ID: 23652661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
    Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
    Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
    Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
    Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.